Sofosbuvir/velpatasvir/voxilaprevir
id:
sofosbuvir-velpatasvir-voxilaprevir-184-15078194
title:
Sofosbuvir/velpatasvir/voxilaprevir
text:
Sofosbuvir/velpatasvir/voxilaprevir, sold under the brand name Vosevi, is a fixed-dose combination medication for the treatment of hepatitis C. It contains sofosbuvir, a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor; velpatasvir, an HCV NS5A inhibitor; and voxilaprevir an HCV NS3/4A protease inhibitor. The most common adverse reactions include headache, fatigue, diarrhea, and nausea. The combination was approved for medical use in the United States and in the European Union
brand slug:
wiki
category slug:
encyclopedia
description:
Combination drug
original url:
https://en.wikipedia.org/wiki/Sofosbuvir/velpatasvir/voxilaprevir
date created:
2017-12-27T12:17:29Z
date modified:
2024-09-07T13:47:59Z
main entity:
{"identifier":"Q48564241","url":"https://www.wikidata.org/entity/Q48564241"}
image:
fields total:
13
integrity:
15